The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
about
Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes.Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interactionDrug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Characterization of cardamonin metabolism by P450 in different species via HPLC-ESI-ion trap and UPLC-ESI-quadrupole mass spectrometryBig physics, small doses: the use of AMS and PET in human microdosing of development drugs.Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4.Interaction index and different methods for determining drug interaction in combination therapy.Interspecies considerations in the evaluation of human food safety for veterinary drugs.Human clearance prediction: shifting the paradigm.Characterization of nuciferine metabolism by P450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals.Microdosing: current and the future.Substrate-specific pharmacokinetic interaction between endothelin receptor antagonists and phosphodiesterase-5 inhibitors--assembling the clues.An update on metabolism studies using human hepatocytes in primary culture
P2860
Q30793532-EBE6FADA-A1A3-4064-9CD9-AB5A297E5237Q31146882-402B3565-6064-4E5F-A1A9-2C9EE70CC232Q33509452-31CA48B9-2CA5-4892-A87C-D95271E6A8D8Q33555599-1D3E8798-AF6A-41FA-B234-C8D85F2B39D9Q35075780-6F608A64-0AB9-44F8-9906-732D10E99B9EQ36257083-5DC6D57A-7C4F-4BEB-B79B-4932B86D0E1BQ36811252-70FF6420-75E4-44AA-AA44-92D4D7D37803Q37361815-6F9110FF-D6D4-4C79-9EEA-A962B4DCFEB0Q37554400-6038FAEB-AE73-4E08-8D31-913338A26705Q37729174-4BE38DF2-0797-4940-ABC9-44A73252993FQ37810237-488CB5E3-AAB2-435C-82FF-38A556E20531Q43132024-FA861B05-AF3C-4B56-B71D-348BCD31C272Q58680978-321A27F3-8433-46D2-A926-76E9E79B799C
P2860
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@ast
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@en
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@nl
type
label
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@ast
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@en
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@nl
prefLabel
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@ast
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@en
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@nl
P356
P1476
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.
@en
P2093
P304
P356
10.2174/1389200013338504
P407
P577
2001-09-01T00:00:00Z